Pyridostatin
CAS: 1085412-37-8
Ref. 3D-FP34924
| 1mg | Discontinued | ||
| 2mg | Discontinued | ||
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued |
Product Information
- 4-(2-Aminoethoxy)-N2,N6-bis[4-(2-aminoethoxy)-2-quinolinyl]-2,6-pyridinedicarboxamide
Pyridostatin is a cyclic peptide that has shown to be effective in the treatment of squamous cell carcinoma. It binds to DNA and inhibits the transcription of genes, which is important for cancer cells. Pyridostatin has been shown to be a stable complex with DNA in vitro assays. It has also been shown to inhibit protein synthesis in bacteria and yeast. The detection sensitivity of pyridostatin is high, making it a good candidate for use as an analytical method for DNA sequencing. Pyridostatin has been shown to have clinical relevance in tissue culture and model systems, where it was effective against various types of cancer cells as well as bacterial infection. This molecule may also be useful as a chemical biology tool due to its ability to bind specifically with double-stranded DNA templates and its low cytotoxicity.
